To minimize these events, Sean Wharton, MD, director of the Wharton Medical Clinic in Toronto, and colleagues suggest the three Es: E ducation and explanation E scalation to an appropriate dose E ffective management of GI side effects. Patients should be counseled on means to decrease adverse event risk such as reducing meal size
A 2025 systematic review mapped weight change after stopping anti-obesity medicines across 11 RCTs
Weniger hufige Nebenwirkungen, die in der Studie beobachtet wurden, waren Gallensteine und leichte Formen einer akuten Bauchspeicheldrsenentzndung
Expert reviews differ on whether lean MASLD patients should aim for weight loss
Depending on clinical appropriateness and availability, treatment may involve FDA-approved GLP-1 medications or compounded GLP-1 formulations prepared by licensed pharmacies
When GLP-1 activity is healthy, appetite is better regulated, blood sugar stays more stable, and the tendency to overeat is reduced